Dr. Jonathan D. Quick, MSH President and CEO, to Transition into a New Role Focusing on Global Health Security
Medford, Massachusetts – Dr. Jonathan D. Quick, MD, MPH, President and CEO of Management Sciences for Health (MSH), an international nonprofit dedicated to saving lives by building strong health systems in some of the world’s poorest communities, has announced his decision to step down and transition into a new role of MSH Senior Fellow once a successor is appointed. Dr. Quick will focus on MSH’s work in global health security, providing strategic support to the multipartner No More Epidemics campaign, and maximize the impact of MSH’s forthcoming book The End of Epidemics: The Looming Threat to Humanity and How to Stop it. Dr. Quick will remain Chair of the Global Health Council.
In 2012, MSH embarked on a five-year Strategic Roadmap to guide the creation of strong health systems. As this roadmap will come to an end in 2017, Dr. Quick announced to the Board of Directors his desire to let a new leader take over the helm of the 45-year-old organization. Until a new president takes office, Dr. Quick will continue to actively lead MSH.
Dr. Quick’s leadership ushered an era of growth in reach and impact for MSH, with annual revenues more than tripling and unrestricted net assets quadrupling during his 12-year tenure. Over that period, MSH grew from 850 people in 30 country offices to more than 2,500 people in over 40 countries, a majority of them local staff.
“MSH has made remarkable progress during Dr. Quick’s tenure as President and CEO,” said Lawrence Fish, Board Chairman of MSH. “Thanks to his leadership, the organization is poised to continue the important work of saving lives and improving the health of the world’s most vulnerable people. The Board is working with Jono toward a smooth transition and aims to have new leadership in place around year-end.”
“I have had the great joy and personal satisfaction of working with a tremendously talented and professionally diverse global team from more than 70 countries and literally every part of the globe,” said Dr. Quick. “The most memorable part of this journey for me has been seeing firsthand the contributions that all ‘MSHers,’ present and past, have made to healthier, longer lives for literally millions of people in the communities and countries we serve.”
Among MSH’s achievements is its support of one of the largest public health supply chains in the world for the US government, with millions of patients and families in more than 120 countries benefiting from safe, secure, and reliable supply chains for medicines and supplies. The organization has also produced a generation of health managers who lead; improved pharmaceutical systems in many countries around the globe; led the widely recognized rebuilding of the Afghan health system; created the first large-scale community-based AIDS prevention and treatment program in Africa; developed innovative large-scale programs for accredited medicines dispensing outlets; and unlocked billions of dollars in Global Fund grants that have saved countless lives in scores of countries.
A recent development under Dr. Quick’s watch includes MSH’s investment in global advocacy for public health. Dr. Quick is a recognized leader on advocacy for universal health coverage. MSH led the “Health for All: The Campaign for Universal Health Coverage in Africa” as well as the “Health for All Post 2015” coalition that led to universal health coverage being included in the Sustainable Development Goals.
The addition in 2015 of the FCI Program of MSH –consisting of staff and programs from the former organization Family Care International (FCI), the leading global advocate for women’s health and rights—builds on MSH’s international network and works to strengthen the capacity of national organizations, health workers, grassroots groups, and government partners to advocate for improved reproductive and maternal health services, access to high-quality care, and respect for human rights in their own countries and communities. Dr. Quick also engaged in advocacy efforts on chronic diseases for the NCD Alliance. He will continue to work as an advocate on global health security with the No More Epidemics® campaign, led by MSH, Save the Children, International Medical Corps, and AFENET.
Dr. Quick joined MSH as a medical student intern in 1978 and was later the founding director of the organization’s drug management program, resulting in the publication of the groundbreaking Managing Drug Supply, the leading reference on how to manage essential medicines in developing countries. Dr. Quick has carried out assignments in more than 60 countries in Africa, Asia, Latin America, and the Middle East. He was Director of Essential Drugs and Medicines Policy at the World Health Organization from 1996 to 2004 and then returned to MSH as President and CEO.
“We first hired Jono Quick in 1978 as a third-year medical student passionate about making a difference in the world,” said Ronald O’Connor, founder and former CEO of MSH. “Over the succeeding years, his passion, dedication, and intellect made him a promising choice to guide MSH’s contribution to enabling millions of people make better choices for their own lives and health in challenging circumstances.”
Dr. Quick, co-author of the Financial Times Guide to Executive Health, has written more than 70 other books, articles, and chapters. He is on the faculty of Harvard Medical School Department of Global Health and Social Medicine and Boston University School of Public Health, and was a Fellow of the Royal Society of Medicine. He has a first degree from Harvard University and an MD, with distinction in research, and masters of public health from the University of Rochester.
Dr. Quick is also the author of The End of Epidemics: The Looming Threat to Humanity and How to Stop It (forthcoming from St. Martin’s Press/Scribe in 2017).
Follow Dr. Quick on Twitter: @jonoquick